[go: up one dir, main page]

NO996086L - Benzimidazolderivater - Google Patents

Benzimidazolderivater

Info

Publication number
NO996086L
NO996086L NO996086A NO996086A NO996086L NO 996086 L NO996086 L NO 996086L NO 996086 A NO996086 A NO 996086A NO 996086 A NO996086 A NO 996086A NO 996086 L NO996086 L NO 996086L
Authority
NO
Norway
Prior art keywords
benzimidazole
Prior art date
Application number
NO996086A
Other languages
English (en)
Other versions
NO314847B1 (no
NO996086D0 (no
Inventor
Stanley Dawes Chamberlain
Susan Mary Daluge
David Norman Deaton
George Andrew Freeman
John C Drach
Leroy B Townsend
Jr Frank L Boyd
Marc W Andersen
Original Assignee
Glaxo Group Ltd
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9711982.0A external-priority patent/GB9711982D0/en
Priority claimed from GBGB9714552.8A external-priority patent/GB9714552D0/en
Application filed by Glaxo Group Ltd, Univ Michigan filed Critical Glaxo Group Ltd
Publication of NO996086D0 publication Critical patent/NO996086D0/no
Publication of NO996086L publication Critical patent/NO996086L/no
Publication of NO314847B1 publication Critical patent/NO314847B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19996086A 1997-06-10 1999-12-09 Benzimidazolderivater, anvendelse derav samt farmasöytisk blanding NO314847B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711982.0A GB9711982D0 (en) 1997-06-10 1997-06-10 Benzimidazole derivatives
GBGB9714552.8A GB9714552D0 (en) 1997-07-11 1997-07-11 Benzimidazole derivatives
PCT/EP1998/003380 WO1998056761A2 (en) 1997-06-10 1998-06-08 Benzimidazole derivatives

Publications (3)

Publication Number Publication Date
NO996086D0 NO996086D0 (no) 1999-12-09
NO996086L true NO996086L (no) 2000-02-09
NO314847B1 NO314847B1 (no) 2003-06-02

Family

ID=26311687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19996086A NO314847B1 (no) 1997-06-10 1999-12-09 Benzimidazolderivater, anvendelse derav samt farmasöytisk blanding

Country Status (35)

Country Link
US (1) US6455507B1 (no)
EP (1) EP0994890B1 (no)
JP (1) JP4548866B2 (no)
KR (1) KR20010020465A (no)
CN (1) CN1265665A (no)
AP (1) AP1262A (no)
AR (1) AR012964A1 (no)
AT (1) ATE246700T1 (no)
AU (1) AU740792C (no)
BR (1) BR9810745A (no)
CA (1) CA2293470C (no)
CO (1) CO4970737A1 (no)
DE (1) DE69816992T2 (no)
DK (1) DK0994890T3 (no)
EA (1) EA002305B1 (no)
EE (1) EE9900564A (no)
ES (1) ES2205527T3 (no)
HK (1) HK1024921A1 (no)
HR (1) HRP980303B1 (no)
HU (1) HUP0002224A3 (no)
ID (1) ID24054A (no)
IL (1) IL133285A0 (no)
IS (1) IS5285A (no)
MA (1) MA26504A1 (no)
MY (1) MY132872A (no)
NO (1) NO314847B1 (no)
NZ (1) NZ501415A (no)
OA (1) OA11230A (no)
PE (1) PE84099A1 (no)
PL (1) PL337773A1 (no)
PT (1) PT994890E (no)
SK (1) SK171499A3 (no)
TR (1) TR199903053T2 (no)
TW (1) TW565566B (no)
WO (1) WO1998056761A2 (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707185A (pt) 1996-01-23 1999-03-23 Glaxo Group Ltd Nucleosídeos de benzimidazol modificados como agentes antivirais
CA2297076A1 (en) 1997-07-30 1999-02-11 The Regents Of The University Of Michigan Lyxofuranosyl benzimidazoles as antiviral agents
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
GB0008939D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
BR0208010A (pt) 2001-03-12 2004-12-21 Avanir Pharmaceuticals Composto de benzimidazol para modulação de ige e inibição de proliferação celular
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
WO2004024655A2 (en) 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
WO2005012242A2 (en) * 2003-08-01 2005-02-10 Janssen Pharmaceutica Nv Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
WO2005049582A1 (en) * 2003-11-14 2005-06-02 Auspex Pharmaceuticals, Inc. Method of preparation of novel nucleoside analogs and uses
CA2598690C (en) * 2005-02-22 2011-11-15 The Regents Of The University Of Michigan Small molecule inhibitors of mdm2 and uses thereof
DE102005019549A1 (de) * 2005-04-25 2006-12-14 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Diaminobenzimidazol
US7989422B2 (en) * 2005-12-22 2011-08-02 Alchemia Limited Antibacterial agents
US10238599B2 (en) 2006-01-19 2019-03-26 The Regents Of The University Of Michigan Composition and method for treating congenital cytomegalovirus induced hearing loss
US8338397B2 (en) 2006-01-19 2012-12-25 The Regents Of The University Of Michigan Composition and method of treating side effects from antibiotic treatment
US8927528B2 (en) 2006-01-19 2015-01-06 The Regents Of The University Of Michigan Composition for treating hearing loss
US9919008B2 (en) 2006-01-19 2018-03-20 The Regents Of The University Of Michigan Method for treating age-related hearing loss (ARHL)
US9889156B2 (en) 2006-01-19 2018-02-13 The Regents Of The University Of Michigan Method for treating noise-induced hearing loss (NIHL)
US9770433B2 (en) 2006-01-19 2017-09-26 The Regents Of The University Of Michigan Composition and method for treating tinnitus
US7951845B2 (en) 2006-01-19 2011-05-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
USRE46372E1 (en) 2006-01-19 2017-04-25 The Regents Of The Univerity Of Michigan Method for treating hearing loss
CN101821277B (zh) 2007-08-15 2014-05-07 Isis制药公司 四氢吡喃核酸类似物
US8987468B2 (en) * 2008-02-04 2015-03-24 The Translational Genomics Research Institute Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
US8530640B2 (en) 2008-02-07 2013-09-10 Isis Pharmaceuticals, Inc. Bicyclic cyclohexitol nucleic acid analogs
AU2009296820B2 (en) 2008-09-26 2014-03-20 Merck Sharp & Dohme Llc Novel cyclic benzimidazole derivatives useful anti-diabetic agents
EP2348857B1 (en) 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CA2741300A1 (en) 2008-10-29 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US8329914B2 (en) 2008-10-31 2012-12-11 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
US20120021515A1 (en) 2009-02-06 2012-01-26 Swayze Eric E Oligomeric compounds and methods
WO2010090969A1 (en) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
WO2011106273A1 (en) 2010-02-25 2011-09-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
WO2011139702A2 (en) 2010-04-28 2011-11-10 Isis Pharmaceuticals, Inc. Modified nucleosides and oligomeric compounds prepared therefrom
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
WO2014134493A1 (en) * 2013-03-01 2014-09-04 Los Alamos National Security, Llc Broad spectrum antibiotic compounds and use thereof
WO2015168172A1 (en) 2014-04-28 2015-11-05 Isis Pharmaceuticals, Inc. Linkage modified oligomeric compounds
US10077242B2 (en) * 2014-12-01 2018-09-18 Virginia Commonwealth University Convergent approach to the total synthesis of telmisartan via a suzuki cross-coupling reaction
RU2629670C2 (ru) * 2016-08-04 2017-08-31 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) 2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа
KR102583547B1 (ko) 2020-03-30 2023-10-06 (주)바이오메트릭스 테크놀로지 신규한 벤지미다졸 유도체, 이의 제조방법 및 이의 항암제 용도
EP3907230B1 (en) * 2020-03-30 2024-08-28 Biometrix Technology Inc. Novel benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same
KR102449266B1 (ko) 2020-06-23 2022-09-30 (주)바이오메트릭스 테크놀로지 항암 활성 그리고 항바이러스 활성을 갖는 신규한 벤지미다졸-탄수화물 결합체 화합물(Benzimidazole carbohydrate conjugate compound) 및 이의 제조 방법
EP4169930A4 (en) 2020-06-23 2024-07-24 Biometrix Technology Inc. NEW BENZIMIDAZOLE DERIVATIVE, PROCESS FOR ITS PREPARATION AND ITS USE AS ANTI-CANCER OR ANTI-VIRAL AGENT
KR102342313B1 (ko) 2021-08-27 2021-12-24 (주)바이오메트릭스 테크놀로지 벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1491244A (fr) 1966-03-09 1967-08-11 Nouveaux benzimidazoles solubles
FR1476350A (fr) 1966-04-18 1967-04-07 Yale & Towne G M B H Ferme-porte automatique à frein
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
DE2130030A1 (de) 1971-06-18 1972-12-21 Bayer Ag Fungizide und bakterizide Mittel
ES482789A0 (es) 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
DK405988A (da) 1987-07-29 1989-01-30 Hoffmann La Roche Benzimidazolderivater
IT1226100B (it) 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
ZA923640B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
EP0521463A3 (en) 1991-07-04 1993-04-14 Hoechst Aktiengesellschaft Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
WO1994008456A1 (en) 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
US5399580A (en) 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
TW565566B (en) 2003-12-11
MA26504A1 (fr) 2004-12-20
MY132872A (en) 2007-10-31
EA199901031A1 (ru) 2000-06-26
ID24054A (id) 2000-07-06
PL337773A1 (en) 2000-09-11
WO1998056761A3 (en) 1999-04-15
JP2002504105A (ja) 2002-02-05
AR012964A1 (es) 2000-11-22
PE84099A1 (es) 1999-09-24
CA2293470C (en) 2008-05-13
TR199903053T2 (xx) 2000-11-21
DK0994890T3 (da) 2003-12-01
AP9901707A0 (en) 1999-12-31
ES2205527T3 (es) 2004-05-01
HUP0002224A1 (hu) 2001-04-28
AU740792B2 (en) 2001-11-15
CN1265665A (zh) 2000-09-06
DE69816992T2 (de) 2004-07-22
ATE246700T1 (de) 2003-08-15
NO314847B1 (no) 2003-06-02
SK171499A3 (en) 2000-08-14
BR9810745A (pt) 2001-03-13
EA002305B1 (ru) 2002-02-28
OA11230A (en) 2003-07-09
DE69816992D1 (en) 2003-09-11
AU740792C (en) 2003-01-23
AU8536098A (en) 1998-12-30
EE9900564A (et) 2000-06-15
EP0994890B1 (en) 2003-08-06
IS5285A (is) 1999-12-06
HUP0002224A3 (en) 2003-05-28
NZ501415A (en) 2001-10-26
AP1262A (en) 2004-03-16
HRP980303B1 (en) 2002-08-31
JP4548866B2 (ja) 2010-09-22
HRP980303A2 (en) 1999-04-30
PT994890E (pt) 2003-11-28
WO1998056761A2 (en) 1998-12-17
IL133285A0 (en) 2001-04-30
US6455507B1 (en) 2002-09-24
CA2293470A1 (en) 1998-12-17
HK1024921A1 (en) 2000-10-27
NO996086D0 (no) 1999-12-09
EP0994890A2 (en) 2000-04-26
KR20010020465A (ko) 2001-03-15
US20020094963A1 (en) 2002-07-18
CO4970737A1 (es) 2000-11-07

Similar Documents

Publication Publication Date Title
DK0994890T3 (da) Benzimidazolderivater
DE69738301D1 (de) Wirbelsäulendistraktionsimplantat
DE69833983D1 (de) Tintenzuführsystemadapter
DE59809130D1 (de) Barhocker
DE69827636D1 (de) Blutverdünnungsreagenz
DE69801567D1 (de) Polyisocyanataerogel
DE69804327D1 (de) Notfluchtatemgerät
DE69828699D1 (de) Vacuumzerstäubungsgerät
DE59811837D1 (de) Wischblatt
DE69831786D1 (de) Kommutationsregler
DE59808447D1 (de) Kabelhalter
DE69804751D1 (de) Estersynthese
DE69803626D1 (de) Waschmitteleinspülvorrichtung
DE69805128D1 (de) Wärmübertragungsdrucker
DE69835876D1 (de) Farbübertragungsinhibierungssystem
FI972138A0 (fi) Returtraog i bestrykningsanordning
EP1039923A4 (en) GAMMA conopeptides
DE59800820D1 (de) Stiellose kniegelenkendoprothese
ATA46498A (de) Kunststoffgleitbahn
FI971651A0 (fi) Spaormaskin i en elmaskin
FI971698A0 (fi) Klingstyrenhet i en cirkelsaog
FI972891A0 (fi) I en vaeggkonstruktion infaellbart faerdigt elkanalnaet
BR9701099A (pt) Acertrol i
FI971123A0 (fi) Foervarings- och transportredskap i synnerhet foer pappersprodukter
FI972640A0 (fi) Gapformare i en pappersmaskin/kartongmaskin

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees